2-(4-(TRIFLUOROMETHYL)THIAZOL-2-YL)ACETONITRILE, 95.0%, 250mg

2,6-Dimethyl-4-tert-butylbenzenesulfonyl chloride, 5g

1-Phenyladamantane, 95.0%, 1g

EDTA zinc, min. 96%, for synthesis, 500 g, plastic packaging.

Potassium D-erythronate, 98%, 25g

(S)-4-(TERT-BUTOXYCARBONYL)-4-AZASPIRO[2.4]HEPTANE-5-CARBOXYLIC ACID, 95.0%, 250mg

5-Chlorobenzo[d]thiazole, 95.0%, 1g

Benzenesulfohydroxamic Acid>98.0%(HPLC)(T)5g

1-(4-Hydroxy-3,5-dimethoxyphenyl)propan-2-one, 95.0%, 100mg

N-(Benzo[d]isoxazol-3-yl)-4-methylbenzamide, 98+%, 100mg

(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-amine hydrochloride, 100mg

methyl 5-amino-1-(4-nitrophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 2g

2-Amino-5-(trifluoromethyl)benzoic acid, 95.0%, 500g